LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 11.18 | 84.90 | 2 | 492 | 0.0041 | -0.7719 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 11.18 | 84.90 | 826 | 492 | 1.6776 | 1.4527 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 11.18 | 84.90 | 2 | 492 | 0.0041 | -0.7719 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 11.18 | 84.90 | 1222 | 492 | 2.4819 | 1.8623 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 12.88 | 84.90 | 9 | 531 | 0.0169 | -0.5719 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 12.88 | 84.90 | 878 | 531 | 1.6535 | 1.4188 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 12.88 | 84.90 | 4 | 531 | 0.0075 | -0.6850 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 12.88 | 84.90 | 1282 | 531 | 2.4143 | 1.7910 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 14.58 | 84.90 | 6 | 663 | 0.0090 | -0.5907 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 14.58 | 84.90 | 932 | 663 | 1.4049 | 1.2429 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 14.58 | 84.90 | 10 | 663 | 0.0151 | -0.5138 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 14.58 | 84.90 | 1351 | 663 | 2.0365 | 1.5419 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 16.29 | 84.90 | 22 | 766 | 0.0287 | -0.3464 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 16.29 | 84.90 | 999 | 766 | 1.3027 | 1.1737 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 16.29 | 84.90 | 25 | 766 | 0.0326 | -0.3196 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 16.29 | 84.90 | 1480 | 766 | 1.9300 | 1.4601 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 17.99 | 84.90 | 18 | 898 | 0.0200 | -0.3659 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 17.99 | 84.90 | 1072 | 898 | 1.1925 | 1.1061 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 17.99 | 84.90 | 20 | 898 | 0.0222 | -0.3460 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 17.99 | 84.90 | 1590 | 898 | 1.7687 | 1.3647 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 19.69 | 84.90 | 38 | 1239 | 0.0307 | -0.1877 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 19.69 | 84.90 | 1190 | 1239 | 0.9601 | 0.9791 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 19.69 | 84.90 | 30 | 1239 | 0.0242 | -0.2358 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 19.69 | 84.90 | 1711 | 1239 | 1.3805 | 1.1739 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 21.40 | 84.90 | 32 | 1454 | 0.0220 | -0.2118 | MN20160318_Q02 | E19 |